FDA proposes rare-disease therapy fast track
WASHINGTON, Feb. 23, 2026 — The U.S. Food and Drug Administration proposed a new “plausible mechanism” framework to speed approvals of individualized therapies for rare, life‑threatening genetic diseases, allowing developers…